Monsanto considers pulling out of Argentina due to GMO soy royalty controversy

e a da d e d a e d

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Agricultural heavyweight Monsanto could be set to pull its biotech soybean seeds from Argentina with the firm currently undertaking a “full review” of its “business plan in the country,” reports said [May 10].

Such a move — reportedly prompted by recent difficulties over collecting seed royalties and the changing value of the local currency — would drastically reshape the country’s huge agricultural sector, with Argentina at the moment being one of the firm’s biggest overseas markets.

According to a report [May 10] by The Wall Street Journal, the multinational giant is far from satisfied with the current state of affairs in Argentina. The conglomerate is currently locked in talks with the government over its controversial royalty-collection plan, which the firm argues is essential in order to make a profit. The plan refers to key genetically enhanced soybeans seeds.

ADVERTISEMENT

Under Monsanto’s previous terms of use for the seeds, which are known as Intacta Soy and were developed to be more insect and glysophate resistant for Argentina, farmers had to pay royalties when purchasing the seed, an option chosen by 70 percent, or when handing over the grain to be exported.

. . . .

According to the government’s new rules, Monsanto won’t be able to collect royalties — a move that has led the firm to apparently reconsider its holdings and business in Argentina.

. . . .

ADVERTISEMENT
ADVERTISEMENT

Argentina is considered a key market for many agricultural firms, ranking as one of the world’s top crop-producing countries. . . Monsanto, for example, took in more than five percent of its US$15-billion sales turnover in the country through seeds and herbicides. . . .

Read full, original post: Monsanto mulls exit from Argentine market

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend